Abstract:Myocardial infarction (MI) is a serious complication of coronary artery disease. This condition is common worldwide and has a profound impact on patients' lives and quality of life. Despite significant advances in the treatment of heart disease in modern medicine, the efficient treatment of MI still faces a number of challenges. Problems such as scar formation and loss of myocardial function after a heart attack still limit patients' recovery. Therefore, the search for a new therapeutic tool that can promote repair and regeneration of myocardial tissue has become crucial. In this context, mesenchymal stromal cells (MSCs) have attracted much attention as a potential therapeutic tool. MSCs are a class of adult stem cells with multidirectional differentiation potential, derived from bone marrow, fat, placenta and other tissues, and possessing properties such as self-renewal and immunomodulation. The application of MSCs may provide a new direction for the treatment of MI. These stem cells have the potential to differentiate into cardiomyocytes and vascular endothelial cells in damaged tissue and to repair and protect myocardial tissue through anti-inflammatory, anti-fibrotic and pro-neovascularization mechanisms. However, the clinical results of MSCs transplantation for the treatment of MI are less satisfactory due to the limitations of the native function of MSCs. Genetic modification has overcome problems such as the low survival rate of transplanted MSCs in vivo and enhanced their functions of promoting neovascularization and differentiation into cardiomyocytes, paving the way for them to become an effective tool for repair therapy after MI. In previous studies, MSCs have shown some therapeutic potential in experimental animals and preliminary clinical trials. This review aims to provide readers with a comprehensive and in-depth understanding to promote the wider application of engineering MSCs in the field of MI therapy, offering new hope for recovery and improved survival of cardiac patients.

Advances in the Treatment of Ischemic Diseases by Mesenchymal Stem Cells

Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases

Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke

Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke.

Treatment of Ischemic Stroke with Modified Mesenchymal Stem Cells

Classification and Characteristics of Mesenchymal Stem Cells and Its Potential Therapeutic Mechanisms and Applications against Ischemic Stroke.

Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier

Mesenchymal Stem Cells and Vascular Regeneration.

Treatment of Heart Failure after Myocardial Infarction with Bone Marrow-derived Mesenchymal Stem Cells

The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments

The therapeutic potential of mesenchymal stem cells for cardiovascular diseases

Potential Mechanism and Perspectives of Mesenchymal Stem Cell Therapy for Ischemic Stroke: A Review

Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke

Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy

[Advances of Bone Marrow Mesenchymal Stem Cells Grafting in the Treatment of Ischemic Cerebral Vascular Disease].

Research Progress on Mesenchymal Stem Cells for the Treatment of Diabetes and Its Complications

Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction

The Current Controversies in the Treatment of Ischemic Nephropathy and Prospection in the Application of Mesenchymal Stem Cells

Efficacy and safety of mesenchymal stem cell therapies for ischemic stroke: a systematic review and meta-analysis

Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis

Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction.